Cell therapy-a 21st century hope for treating cardiovascular disease-a five-year retrospective and predictive view.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4354701)

Published in Am Heart Hosp J on January 01, 2011

Authors

Doris A Taylor1

Author Affiliations

1: Center for Cardiovascular Repair, University of Minnesota, Minneapolis, USA. ccvr@umn.edu

Associated clinical trials:

CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction (CADUCEUS) | NCT00893360

Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO) (SCIPIO) | NCT00474461

Use of Adult Autologous Stem Cells in Treating People Who Have Had a Heart Attack (The TIME Study) | NCT00684021

Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study) | NCT00684060

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia (ACT34-CLI) | NCT00616980

The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | NCT00076986

Articles cited by this

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51

Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42

Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50

Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58

Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15

Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet (2006) 7.64

Tissue engineered human tracheas for in vivo implantation. Biomaterials (2010) 1.48

[Current perspectives in cell therapy in cardiology: an overview of ongoing trials]. G Ital Cardiol (Rome) (2010) 1.44

iPS cell technology in regenerative medicine. Ann N Y Acad Sci (2010) 1.23

Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network. JACC Cardiovasc Imaging (2011) 1.05

Atherosclerosis as a disease of failed endogenous repair. Front Biosci (2008) 1.00

In vivo imaging for stem cell therapy: new developments and future challenges. Eur J Nucl Med Mol Imaging (2011) 0.81

Developmental biology. Field leaps forward with new stem cell advances. Science (2007) 0.80